• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血糖控制不佳的糖尿病是慢性阻塞性肺疾病(COPD)患者发生肺炎的一个危险因素。

Diabetes mellitus with poor glycemic control is a risk factor for pneumonia in COPD.

作者信息

Golpe Rafael, Figueira-Gonçalves Juan-Marco, Arias-Zas Laura, Dacal-Rivas David, Blanco-Cid Nagore, Castro-Añón Olalla

机构信息

Servicio de Neumología. Hospital Universitario Lucus Augusti, Lugo, Spain.

Servicio de Neumología y Cirugía Torácica, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; University Institute of Tropical Diseases and Public Health of the Canary Islands, University of La Laguna, Santa Cruz de Tenerife, Spain.

出版信息

Respir Med Res. 2024 Nov;86:101135. doi: 10.1016/j.resmer.2024.101135. Epub 2024 Aug 7.

DOI:10.1016/j.resmer.2024.101135
PMID:39191087
Abstract

BACKGROUND

Pneumonias are events of great prognostic significance in COPD, so it is important to identify predictive factors.

OBJECTIVE

To determine whether poor glycemic control is related to an increased risk of pneumonia in COPD.

METHOD

A historical cohort study conducted in a COPD clinic. The first severe exacerbation after the first visit was analyzed. Exacerbations that presented with pulmonary infiltrates were identified. A Cox proportional hazards analysis was performed including the values of glycosylated hemoglobin (Hb1Ac) in patients with diabetes mellitus (DM) and variables that could plausibly be related to the risk of pneumonia. The best Hb1Ac value to predict pneumonia was assessed using receiver-operating characteristics analysis.

RESULTS

There were 1124 cases included in the study. A total of 411 patients were admitted to the hospital at least once and 87 were diagnosed with pneumonia. Variables associated with the risk of pneumonia were previous admissions due to COPD and Hb1Ac values (HR: 2.33, 95% CI: 1.06 - 5.08, p = 0.03). A higher body mass index (BMI) was associated with a lower risk of pneumonia. The optimal cutoff point for Hb1Ac to predict pneumonia risk was 7.8 %. The patients were classified into 3 groups: (1) no DM, (2) controlled DM (Hb1AC < 7.8 %), (3) uncontrolled DM (Hb1AC ≥ 7.8 %). The risk of pneumonia for group 2 was not different from group 1, while the risk for group 3 was significantly higher than for groups 1 and 2 (HR: 4.52, 95 % CI: 1.57 - 13.02).

CONCLUSIONS

Poor control of DM is a predictor of the risk of pneumonia in COPD. The cutoff point of 7.8 % for this variable seems to be the most useful to identify patients at risk.

摘要

背景

肺炎在慢性阻塞性肺疾病(COPD)中具有重要的预后意义,因此识别预测因素很重要。

目的

确定血糖控制不佳是否与COPD患者肺炎风险增加有关。

方法

在一家COPD诊所进行的历史性队列研究。分析首次就诊后的首次严重加重情况。识别出现肺部浸润的加重情况。进行Cox比例风险分析,纳入糖尿病(DM)患者的糖化血红蛋白(Hb1Ac)值以及可能与肺炎风险相关的变量。使用受试者工作特征分析评估预测肺炎的最佳Hb1Ac值。

结果

该研究共纳入1124例病例。共有411例患者至少入院一次,87例被诊断为肺炎。与肺炎风险相关的变量是既往因COPD入院和Hb1Ac值(风险比:2.33,95%置信区间:1.06 - 5.08,p = 0.03)。较高的体重指数(BMI)与较低的肺炎风险相关。预测肺炎风险的Hb1Ac最佳临界值为7.8%。将患者分为3组:(1)无DM,(2)DM控制良好(Hb1AC < 7.8%),(3)DM控制不佳(Hb1AC≥7.8%)。第2组的肺炎风险与第1组无差异,而第3组的风险显著高于第1组和第2组(风险比:4.52,95%置信区间:1.57 - 13.‘02)。

结论

DM控制不佳是COPD患者肺炎风险的预测因素。该变量7.8%的临界值似乎是识别高危患者最有用的指标。

相似文献

1
Diabetes mellitus with poor glycemic control is a risk factor for pneumonia in COPD.血糖控制不佳的糖尿病是慢性阻塞性肺疾病(COPD)患者发生肺炎的一个危险因素。
Respir Med Res. 2024 Nov;86:101135. doi: 10.1016/j.resmer.2024.101135. Epub 2024 Aug 7.
2
Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.被诊断患有糖尿病的患者患哮喘、慢性阻塞性肺疾病、肺纤维化和肺炎的风险增加,但肺癌风险并未增加。
Diabetes Care. 2010 Jan;33(1):55-60. doi: 10.2337/dc09-0880. Epub 2009 Oct 6.
3
[Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT].[吸入糖皮质激素或其他支气管扩张剂治疗慢性阻塞性肺疾病患者的社区获得性肺炎。PNEUMOCORT研究]
Aten Primaria. 2019 Jun-Jul;51(6):333-340. doi: 10.1016/j.aprim.2018.02.007. Epub 2018 Apr 13.
4
High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.高体重指数与慢性阻塞性肺疾病患者病情加重及肺炎风险:哥本哈根普通人群研究的观察性和遗传风险评估
Int J Epidemiol. 2016 Oct;45(5):1551-1559. doi: 10.1093/ije/dyw051. Epub 2016 Apr 26.
5
Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies.慢性阻塞性肺疾病患者的糖尿病风险与结局:两项基于全国人群的回顾性队列研究
PLoS One. 2017 Aug 16;12(8):e0181815. doi: 10.1371/journal.pone.0181815. eCollection 2017.
6
Is Uncontrolled Diabetes Mellitus Associated with Incidence of Complications After Posterior Instrumented Lumbar Fusion? A National Claims Database Analysis.未控制的糖尿病与后路器械固定腰椎融合术后并发症的发生有关吗?一项全国性索赔数据库分析。
Clin Orthop Relat Res. 2021 Dec 1;479(12):2726-2733. doi: 10.1097/CORR.0000000000001823.
7
Impact of glycemic control on coccidioidomycosis outcomes in patients with underlying diabetes mellitus in central California.血糖控制对加利福尼亚中部潜在糖尿病患者球孢子菌病结局的影响。
Med Mycol. 2025 Apr 2;63(4). doi: 10.1093/mmy/myaf039.
8
U.K. National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations.英国国家 COPD 资源和结局项目 2008 年:与非肺炎性 COPD 加重患者相比,出现影像学肺炎的 COPD 加重患者的结局更差。
Respiration. 2011;82(4):320-7. doi: 10.1159/000327203. Epub 2011 May 20.
9
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis.慢性阻塞性肺疾病患者加重和肺炎的风险因素:荟萃分析。
Respir Res. 2020 Jan 6;21(1):5. doi: 10.1186/s12931-019-1262-0.
10
Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.使用抗糖尿病药物与需要住院治疗的慢性阻塞性肺疾病恶化风险:疾病风险评分匹配的巢式病例对照研究。
Respir Res. 2020 Dec 2;21(1):319. doi: 10.1186/s12931-020-01547-1.

引用本文的文献

1
Frailty-stratified effectiveness of SGLT2 inhibitors versus DPP-4 inhibitors and GLP-1 receptor agonists on pulmonary outcomes in type 2 diabetes: a nationwide cohort study.钠-葡萄糖协同转运蛋白2抑制剂与二肽基肽酶-4抑制剂及胰高血糖素样肽-1受体激动剂相比,在2型糖尿病患者中基于衰弱分层的肺部结局疗效:一项全国性队列研究
EClinicalMedicine. 2025 Jul 3;85:103332. doi: 10.1016/j.eclinm.2025.103332. eCollection 2025 Jul.
2
Current Evidence on the Usefulness of Potential Therapies in the Prevention of COPD Exacerbations: Beyond the Use of Bronchodilator Therapy and Inhaled Corticosteroids.预防慢性阻塞性肺疾病(COPD)急性加重的潜在疗法有效性的当前证据:超越支气管扩张剂疗法和吸入性糖皮质激素的应用
Open Respir Arch. 2025 May 7;7(2):100438. doi: 10.1016/j.opresp.2025.100438. eCollection 2025 Apr-Jun.
3
Weight-Adjusted Waist Index as a Novel Predictor of Chronic Obstructive Pulmonary Disease: Evidence from NHANES 2013-2018.体重校正腰围指数作为慢性阻塞性肺疾病的新型预测指标:来自2013 - 2018年美国国家健康与营养检查调查的证据
Int J Chron Obstruct Pulmon Dis. 2025 May 22;20:1625-1638. doi: 10.2147/COPD.S513853. eCollection 2025.